Go Pro

BrightSpring Health Services (BTSG) Competitors

BrightSpring Health Services logo
$68.98 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$68.87 -0.11 (-0.17%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BTSG vs. NTRA, GH, FMS, HIMS, and PACS

Should you buy BrightSpring Health Services stock or one of its competitors? MarketBeat compares BrightSpring Health Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BrightSpring Health Services include Natera (NTRA), Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does BrightSpring Health Services compare to Natera?

Natera (NASDAQ:NTRA) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk.

BrightSpring Health Services has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natera$2.31B16.91-$208.16M-$1.63N/A
BrightSpring Health Services$12.91B1.05$190.67M$1.4148.92

99.9% of Natera shares are owned by institutional investors. 5.1% of Natera shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Natera currently has a consensus target price of $260.33, indicating a potential downside of 4.40%. BrightSpring Health Services has a consensus target price of $61.27, indicating a potential downside of 11.18%. Given Natera's higher possible upside, equities analysts clearly believe Natera is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natera
1 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
3 Strong Buy rating(s)
2.86
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11

In the previous week, Natera had 25 more articles in the media than BrightSpring Health Services. MarketBeat recorded 27 mentions for Natera and 2 mentions for BrightSpring Health Services. Natera's average media sentiment score of 0.61 beat BrightSpring Health Services' score of 0.43 indicating that Natera is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Natera
4 Very Positive mention(s)
8 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Natera has a beta of 1.56, meaning that its stock price is 56% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market.

BrightSpring Health Services has a net margin of 2.27% compared to Natera's net margin of -9.05%. BrightSpring Health Services' return on equity of 14.63% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
Natera-9.05% -14.74% -10.27%
BrightSpring Health Services 2.27%14.63%4.41%

Summary

BrightSpring Health Services beats Natera on 10 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to Guardant Health?

Guardant Health (NASDAQ:GH) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, media sentiment, earnings, risk and dividends.

Guardant Health presently has a consensus target price of $144.82, suggesting a potential downside of 5.80%. BrightSpring Health Services has a consensus target price of $61.27, suggesting a potential downside of 11.18%. Given Guardant Health's higher possible upside, equities research analysts clearly believe Guardant Health is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
21 Buy rating(s)
2 Strong Buy rating(s)
3.00
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11

92.6% of Guardant Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$982.02M20.76-$416.28M-$3.39N/A
BrightSpring Health Services$12.91B1.05$190.67M$1.4148.92

Guardant Health has a beta of 1.61, indicating that its stock price is 61% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, indicating that its stock price is 87% more volatile than the broader market.

In the previous week, Guardant Health had 10 more articles in the media than BrightSpring Health Services. MarketBeat recorded 12 mentions for Guardant Health and 2 mentions for BrightSpring Health Services. Guardant Health's average media sentiment score of 0.52 beat BrightSpring Health Services' score of 0.43 indicating that Guardant Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
1 Very Positive mention(s)
5 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

BrightSpring Health Services has a net margin of 2.27% compared to Guardant Health's net margin of -40.10%. BrightSpring Health Services' return on equity of 14.63% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-40.10% N/A -26.42%
BrightSpring Health Services 2.27%14.63%4.41%

Summary

BrightSpring Health Services beats Guardant Health on 9 of the 16 factors compared between the two stocks.

How does BrightSpring Health Services compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

In the previous week, Fresenius Medical Care AG & Co. KGaA and Fresenius Medical Care AG & Co. KGaA both had 2 articles in the media. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.07 beat BrightSpring Health Services' score of 0.43 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $28.00, suggesting a potential upside of 23.09%. BrightSpring Health Services has a consensus price target of $61.27, suggesting a potential downside of 11.18%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to BrightSpring Health Services' net margin of 2.27%. BrightSpring Health Services' return on equity of 14.63% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
BrightSpring Health Services 2.27%14.63%4.41%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than BrightSpring Health Services. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.55$1.11B$1.9011.97
BrightSpring Health Services$12.91B1.05$190.67M$1.4148.92

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.87, indicating that its stock price is 87% more volatile than the broader market.

Summary

BrightSpring Health Services beats Fresenius Medical Care AG & Co. KGaA on 9 of the 16 factors compared between the two stocks.

How does BrightSpring Health Services compare to Hims & Hers Health?

BrightSpring Health Services (NASDAQ:BTSG) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

BrightSpring Health Services has a net margin of 2.27% compared to Hims & Hers Health's net margin of -0.56%. BrightSpring Health Services' return on equity of 14.63% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.27% 14.63% 4.41%
Hims & Hers Health -0.56%6.10%1.52%

BrightSpring Health Services has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B1.05$190.67M$1.4148.92
Hims & Hers Health$2.37B3.26$128.37M-$0.09N/A

63.5% of Hims & Hers Health shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

BrightSpring Health Services currently has a consensus target price of $61.27, suggesting a potential downside of 11.18%. Hims & Hers Health has a consensus target price of $29.37, suggesting a potential downside of 11.96%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, equities analysts plainly believe BrightSpring Health Services is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11
Hims & Hers Health
2 Sell rating(s)
10 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.13

BrightSpring Health Services has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, meaning that its stock price is 137% more volatile than the broader market.

In the previous week, Hims & Hers Health had 14 more articles in the media than BrightSpring Health Services. MarketBeat recorded 16 mentions for Hims & Hers Health and 2 mentions for BrightSpring Health Services. Hims & Hers Health's average media sentiment score of 0.64 beat BrightSpring Health Services' score of 0.43 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hims & Hers Health
6 Very Positive mention(s)
7 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

BrightSpring Health Services beats Hims & Hers Health on 11 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to PACS Group?

BrightSpring Health Services (NASDAQ:BTSG) and PACS Group (NYSE:PACS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

In the previous week, PACS Group had 16 more articles in the media than BrightSpring Health Services. MarketBeat recorded 18 mentions for PACS Group and 2 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.43 beat PACS Group's score of 0.08 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
PACS Group
4 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

PACS Group has lower revenue, but higher earnings than BrightSpring Health Services. PACS Group is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B1.05$190.67M$1.4148.92
PACS Group$5.29B1.20$191.54M$1.5625.60

BrightSpring Health Services presently has a consensus price target of $61.27, suggesting a potential downside of 11.18%. PACS Group has a consensus price target of $48.00, suggesting a potential upside of 20.19%. Given PACS Group's higher possible upside, analysts clearly believe PACS Group is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
3.11
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

PACS Group has a net margin of 4.49% compared to BrightSpring Health Services' net margin of 2.27%. PACS Group's return on equity of 26.47% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.27% 14.63% 4.41%
PACS Group 4.49%26.47%4.36%

Summary

BrightSpring Health Services and PACS Group tied by winning 7 of the 14 factors compared between the two stocks.

Get BrightSpring Health Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTSG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTSG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTSG vs. The Competition

MetricBrightSpring Health ServicesMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$13.61B$9.40B$6.85B$12.20B
Dividend YieldN/A1.66%2.66%6.22%
P/E Ratio48.9225.9526.0424.36
Price / Sales1.0517.07550.39103.01
Price / Cash31.3914.9229.0936.93
Price / Book6.635.9910.986.49
Net Income$190.67M$179.69M$3.57B$336.61M
7 Day Performance2.65%5.72%3.06%0.90%
1 Month Performance11.84%4.93%0.72%-0.36%
1 Year Performance193.03%16.42%36.82%31.26%

BrightSpring Health Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTSG
BrightSpring Health Services
3.3454 of 5 stars
$68.98
flat
$61.27
-11.2%
+193.0%$13.61B$12.91B48.9223,500
NTRA
Natera
1.8587 of 5 stars
$239.54
+4.7%
$256.53
+7.1%
+55.9%$34.34B$2.31BN/A6,140
GH
Guardant Health
1.902 of 5 stars
$134.22
+4.2%
$141.95
+5.8%
+193.4%$17.82B$982.02MN/A2,506
FMS
Fresenius Medical Care AG & Co. KGaA
4.6462 of 5 stars
$23.68
+1.2%
$28.00
+18.3%
-17.7%$12.79B$19.36B12.461,488
HIMS
Hims & Hers Health
2.495 of 5 stars
$34.16
+1.8%
$29.37
-14.0%
-31.5%$7.93B$2.35BN/A2,442

Related Companies and Tools


This page (NASDAQ:BTSG) was last updated on 6/29/2026 by MarketBeat.com Staff.
From Our Partners